WordNet

move from one place to another; "transfer the data"; "transmit the news"; "transfer the patient to another hospital"
the act of transfering something from one form to another; "the transfer of the music from record to tape suppressed much of the background noise" (同)transference
transferring ownership (同)transference
application of a skill learned in one situation to a different but similar situation (同)transfer of training, carry-over
someone who transfers or is transferred from one position to another; "the best student was a transfer from LSU" (同)transferee
a ticket that allows a passenger to change conveyances
change from one vehicle or transportation line to another; "She changed in Chicago on her way to the East coast" (同)change
transfer somebody to a different position or location of work (同)reassign
move around; "transfer the packet from his trouser pockets to a pocket in his jacket" (同)shift
transfer from one place or period to another; "The ancient Greek story was transplanted into Modern America" (同)transpose, transplant
cause to change ownership; "I transferred my stock holdings to my children"
any of a large group of nitrogenous organic compounds that are essential constituents of living cells; consist of polymers of amino acids; essential in the diet of animals for growth and for repair of tissues; can be obtained from meat and eggs and milk and legumes; "a diet high in protein"
of or relating to microsomes

PrepTutorEJDIC

(…から…へ)〈人・物〉‘を'『移す』,移転させる,乗り換えさせる《+名〈人・物〉+from+名+to+名》 / (…から…へ)〈権利・財産など〉‘を'譲り渡す,移転する《+名〈権利・財産〉+from+名+to+名》 / 〈絵画・デザインなど〉‘を'写す,転写する / 〈人が〉(ある人・場所から他の人・場所などへ)『移る』,移される;転任する,転任させられる《+from+名+to+名》 / (…から…へ)列車(バスなど)を乗り換える《+from+名+to+名》 / 〈U〉〈C〉(…を)『移すこと』,(…が)移転されること《+of+名》;転任,転校 / 〈C〉移る人(物),移される人(物);転校生,転任者 / 〈C〉乗り換え切符 / 〈C〉乗り換え場所 / 〈C〉写し絵
蛋白(たんばく)質

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. リポ蛋白の分類、代謝、およびアテローム性動脈硬化症における役割 lipoprotein classification metabolism and role in atherosclerosis
2. 遺伝性運動失調の概要 overview of the hereditary ataxias
3. プロテインS欠乏症：臨床症状および診断 protein s deficiency clinical manifestations and diagnosis
4. 幼児の食物蛋白誘発性直腸炎/大腸炎および腸疾患 food protein induced proctitis colitis and enteropathy of infancy
5. プロテインC欠乏症：臨床症状および診断 protein c deficiency clinical manifestations and diagnosis

Hewing B, Parathath S, Mai CK, Fiel MI, Guo L, Fisher EA.SourceDepartment of Medicine, Division of Cardiology, New York University School of Medicine, New York, NY, USA; Medizinische Klinik für Kardiologie und Angiologie, Campus Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany. Electronic address: bernd.hewing@nyumc.org.
Atherosclerosis.Atherosclerosis.2013 Mar;227(1):125-9. doi: 10.1016/j.atherosclerosis.2012.12.026. Epub 2013 Jan 1.
OBJECTIVE: Regression of atherosclerosis is a vital treatment goal of atherosclerotic vascular disease. Inhibitors of the microsomal triglyceride transfer protein (MTP) have been shown to reduce apolipoprotein B (apoB)-containing lipoproteins in animals and humans effectively. Therefore, the major a
PMID 23332773

Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies.

Chan DC, Pang J, Romic G, Watts GF.SourceMetabolic Research Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. dick.chan@uwa.edu.au
Current atherosclerosis reports.Curr Atheroscler Rep.2013 Mar;15(3):309. doi: 10.1007/s11883-013-0309-9.
Exaggerated postprandial hypertriglyceridemia is a risk factor for cardiovascular disease. This metabolic abnormality is principally due to overproduction and/or decreased catabolism of triglyceride-rich lipoproteins (TRLs) and is a consequence of pathogenic genetic variations and other coexistent m
PMID 23345190

Comparison of the pharmacological profiles of murine antisense oligonucleotides targeting apolipoprotein B and microsomal triglyceride transfer protein.

Lee RG, Fu W, Graham MJ, Mullick AE, Sipe D, Gattis D, Bell TA, Booten S, Crooke RM.SourceCardiovascular Antisense Drug Discovery Group, Isis Pharmaceuticals, Carlsbad, CA 92010.
Journal of lipid research.J Lipid Res.2013 Mar;54(3):602-14. doi: 10.1194/jlr.M029215. Epub 2012 Dec 6.
Therapeutic agents that suppress apolipoprotein B (apoB) and microsomal triglyceride transfer protein (MTP) levels/activity are being developed in the clinic to benefit patients who are unable to reach target LDL-C levels with maximally tolerated lipid-lowering drugs. To compare and contrast the met
PMID 23220583